Streetbeat News

Analyst Ratings

SIG

Telsey Advisory Group has maintained its Market Perform rating on Signet Jewelers with a price target of $87.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 6:37 pm

INZY

Stifel has initiated coverage on Inozyme Pharma Inc. (NASDAQ:INZY) with a Buy rating and a $16 price target, highlighting its lead candidate INZ-701's potential in treating rare diseases. The FDA has granted fast track designation for INZ-701 for ABCC6 Deficiency, and the company plans a pivotal study by the end of 2024.

Portfolio Pulse from Vandana Singh

September 12, 2024 | 6:36 pm

BKH

EVRG

MDU

OGE

BofA Securities analyst Ross Fowler has provided updated ratings and price targets for four US utilities. Evergy and MDU Resources are rated as Buy, with price targets of $66 and $28, respectively, due to favorable growth prospects. OGE Energy is rated Neutral with a $40 target, while Black Hills Corporation is rated Underperform with a $59 target, facing EPS headwinds due to debt maturities.

Portfolio Pulse from Lekha Gupta

September 12, 2024 | 6:30 pm

VAL

Citigroup analyst Nikhil Gupta maintains a Buy rating on Valaris (NYSE:VAL) but lowers the price target from $95 to $71.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 6:29 pm

NE

Citigroup analyst Nikhil Gupta maintains a Buy rating on Noble Corp (NYSE:NE) but lowers the price target from $63 to $45.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 6:27 pm

SDRL

Citigroup analyst Nikhil Gupta has upgraded Seadrill (NYSE:SDRL) from Neutral to Buy, while lowering the price target from $60 to $52.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 6:23 pm

RIG

Citigroup analyst Scott Gruber has downgraded Transocean (NYSE:RIG) from Buy to Neutral, indicating a change in the investment outlook for the company.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 6:20 pm

WOOF

Citigroup analyst Steven Zaccone maintains a Neutral rating on Petco Health and Wellness (NASDAQ:WOOF) and raises the price target from $4 to $4.5.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 6:17 pm

DEI

Citigroup analyst Emmanuel Korchman maintains a Neutral rating on Douglas Emmett (NYSE:DEI) but raises the price target from $14 to $16.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 6:15 pm

CTAS

CFRA analyst Caydee Blankenship has upgraded Cintas (NASDAQ:CTAS) from Strong Sell to Sell and adjusted the price target from $645 to $170, reflecting a 4-1 stock split.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 6:14 pm